Trilogy Evo and Trilogy Ev300
Last updated
Summary
Product
Trilogy Evo and Trilogy Ev300
Issue
Medical devices - Performance
What to do
Contact the manufacturer if you require additional information.
Audience
Healthcare
Affected products
| Affected products | Lot or serial number | Model or catalogue number |
|---|---|---|
| Trilogy Evo | More than 10 numbers, contact manufacturer. | CA2110X12B |
| Trilogy Evo, O2, Canada Ev300 | More than 10 numbers, contact manufacturer. | CA2200X12B |
Issue
Philips Respironics has become aware of a potential issue when using in-line nebulizers in certain configurations with Trilogy Evo and Trilogy Ev300 devices. The use of in-line nebulizers placed in certain locations can result in aerosol deposits accumulating over time on the device's internal flow sensor. Impacted flow sensors may result in inaccurate flow measurements in certain circumstances.
Recall start date: September 18, 2024
Additional information
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - General hospital and personal use
Companies
| Respironics Inc. Also Trading As Philips Rs North America Llc |
| 1001 Murry Ridge Lane, Murrysville, Pennsylvania, United States, 15668 |
Published by
Health Canada
Audience
Healthcare
Recall class
Type I
Identification number
RA-76234
Get notified
Receive emails about new and updated recall and safety alerts.